Home > Insider Trading > Filing (0001209191-15-037172)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1557290	A Stuart Arbuckle	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp\Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2015-04-27	150	$0.00	138,120	No	4	G	Direct
Common Stock	Acquisiton	2015-04-27	18,312	$53.74	156,432	No	4	M	Direct
Common Stock	Acquisiton	2015-04-27	15,563	$45.11	171,995	No	4	M	Direct
Common Stock	Acquisiton	2015-04-27	17,000	$77.31	188,995	No	4	M	Direct
Common Stock	Disposition	2015-04-27	21,480	$127.49	167,515	No	4	S	Direct
Common Stock	Disposition	2015-04-27	12,933	$128.17	154,582	No	4	S	Direct
Common Stock	Disposition	2015-04-27	1,100	$129.30	153,482	No	4	S	Direct
Common Stock	Disposition	2015-04-27	11,321	$130.33	142,161	No	4	S	Direct
Common Stock	Disposition	2015-04-27	4,230	$131.27	137,931	No	4	S	Direct
Common Stock	Disposition	2015-04-27	6,316	$132.44	131,615	No	4	S	Direct
Common Stock	Disposition	2015-04-27	3,400	$133.34	128,215	No	4	S	Direct
Common Stock	Disposition	2015-04-27	700	$134.05	127,515	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	G	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2015-04-27	18,312	$0.00	18,312	$53.74
Common Stock	Stock Option (right to buy)	Disposition	2015-04-27	15,563	$0.00	15,563	$45.11
Common Stock	Stock Option (right to buy)	Disposition	2015-04-27	17,000	$0.00	17,000	$77.31

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
27,188	2022-09-03	No	4	M	Direct
45,312	2023-02-04	No	4	M	Direct
51,000	2024-02-04	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	140	Indirect	401(k)

Footnotes

Represents a gift made to a charitable organization.
Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $127.49 (range $126.88 to $127.87).
Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $128.17 (range $127.88 to $128.82).
Open market sales reported on this line occurred at a weighted average price of $129.30 (range $128.93 to $129.90).
Open market sales reported on this line occurred at a weighted average price of $130.33 (range $129.94 to $130.88).
Open market sales reported on this line occurred at a weighted average price of $131.27 (range $130.94 to $131.92).
Open market sales reported on this line occurred at a weighted average price of $132.44 (range $131.94 to $132.91).
Open market sales reported on this line occurred at a weighted average price of $133.34 (range $132.98 to $133.92).
Open market sales reported on this line occurred at a weighted average price of $134.05 (range $133.99 to $134.09).
The option vests in 16 quarterly installments from 09/04/2012.
The option vests in 16 quarterly installments from 02/05/2013.
The option vests in 16 quarterly installments from 02/05/2014.